Abeona Therapeutics Inc (ABEO.OQ)
ABEO.OQ on NASDAQ Stock Exchange Capital Market
7.34USD
9:00pm BST
7.34USD
9:00pm BST
Change (% chg)
$-0.10 (-1.34%)
$-0.10 (-1.34%)
Prev Close
$7.44
$7.44
Open
$7.41
$7.41
Day's High
$7.48
$7.48
Day's Low
$7.20
$7.20
Volume
70,957
70,957
Avg. Vol
116,269
116,269
52-wk High
$19.15
$19.15
52-wk Low
$6.28
$6.28
About
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)
Overall
| Beta: | 1.91 |
| Market Cap(Mil.): | $365.77 |
| Shares Outstanding(Mil.): | 49.16 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ABEO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 101.85 | 55.51 |
| EPS (TTM): | -1.36 | -- | -- |
| ROI: | -41.22 | 7.41 | 11.59 |
| ROE: | -45.09 | 7.88 | 16.33 |
Estimates